GW0742, a selective PPAR-β/δ agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury

Rosanna Di Paola, Emanuela Esposito, Emanuela Mazzon, Irene Paterniti, Maria Galuppo, Salvatore Cuzzocrea

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

PPARs belong to a subfamily of transcription nuclear factors. Three isoforms of PPARs have been identified: α, β/δ, and γ, encoded by different genes and distributed in various tissues. They play important roles in metabolic processes, such as regulation of glucose and lipid redistribution. They also have antiatherogenic, anti-inflammatory, as well as antihypertensive functions. There is good evidence that ligands of PPARs reduce tissue injury associated with I/R. This study investigated the effects of GW0742, a potent and selective PPAR-β/δ agonist, on tissue injury, caused in a mouse model of SAO shock. IRI of the intestine was caused by clamping the superior mesenteric artery and the celiac trunk for 45 min, followed by release of the clamp, allowing reperfusion for 1 or 6 h. Only 10% of the SAO animals survived the entire 6-h reperfusion period. In a separate set of experiments after 60 min of reperfusion, animals were killed for histological examination and biochemical studies. Administration of GW0742 (0.1 mg/ kg, i.p.), 5 min prior to reperfusion, significantly reduced the (1) mortality rate, (2) histological evidence of gut injury, (3) MPO activity, (4) proinflammatory cytokines (TNF-α, IL-1β), (5) adhesion molecules (ICAM-1, P-selectin), (6) nitrotyrosine formation, (7) NF-κB expression, (8) PAR formation, and (9) apoptosis (Bax, Bcl-2, Fas-L, and TUNEL). Based on these findings, we propose that GW0742 would be useful in the treatment of various I/R diseases.

Original languageEnglish
Pages (from-to)291-301
Number of pages11
JournalJournal of Leukocyte Biology
Volume88
Issue number2
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Peroxisome Proliferator-Activated Receptors
Reperfusion Injury
Reperfusion
Inflammation
Wounds and Injuries
P-Selectin
Superior Mesenteric Artery
Interleukin-5
In Situ Nick-End Labeling
Intercellular Adhesion Molecule-1
Interleukin-1
Constriction
Abdomen
Antihypertensive Agents
Intestines
Shock
Protein Isoforms
Anti-Inflammatory Agents
Transcription Factors
Apoptosis

Keywords

  • Apoptosis
  • MPO activity
  • NF-κB expression
  • Nitrosative stress
  • Proinflammatory cytokines
  • SAO shock

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this

GW0742, a selective PPAR-β/δ agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury. / Di Paola, Rosanna; Esposito, Emanuela; Mazzon, Emanuela; Paterniti, Irene; Galuppo, Maria; Cuzzocrea, Salvatore.

In: Journal of Leukocyte Biology, Vol. 88, No. 2, 08.2010, p. 291-301.

Research output: Contribution to journalArticle

Di Paola, Rosanna ; Esposito, Emanuela ; Mazzon, Emanuela ; Paterniti, Irene ; Galuppo, Maria ; Cuzzocrea, Salvatore. / GW0742, a selective PPAR-β/δ agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury. In: Journal of Leukocyte Biology. 2010 ; Vol. 88, No. 2. pp. 291-301.
@article{e98c9742ee9343dd80305a5447c63ac2,
title = "GW0742, a selective PPAR-β/δ agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury",
abstract = "PPARs belong to a subfamily of transcription nuclear factors. Three isoforms of PPARs have been identified: α, β/δ, and γ, encoded by different genes and distributed in various tissues. They play important roles in metabolic processes, such as regulation of glucose and lipid redistribution. They also have antiatherogenic, anti-inflammatory, as well as antihypertensive functions. There is good evidence that ligands of PPARs reduce tissue injury associated with I/R. This study investigated the effects of GW0742, a potent and selective PPAR-β/δ agonist, on tissue injury, caused in a mouse model of SAO shock. IRI of the intestine was caused by clamping the superior mesenteric artery and the celiac trunk for 45 min, followed by release of the clamp, allowing reperfusion for 1 or 6 h. Only 10{\%} of the SAO animals survived the entire 6-h reperfusion period. In a separate set of experiments after 60 min of reperfusion, animals were killed for histological examination and biochemical studies. Administration of GW0742 (0.1 mg/ kg, i.p.), 5 min prior to reperfusion, significantly reduced the (1) mortality rate, (2) histological evidence of gut injury, (3) MPO activity, (4) proinflammatory cytokines (TNF-α, IL-1β), (5) adhesion molecules (ICAM-1, P-selectin), (6) nitrotyrosine formation, (7) NF-κB expression, (8) PAR formation, and (9) apoptosis (Bax, Bcl-2, Fas-L, and TUNEL). Based on these findings, we propose that GW0742 would be useful in the treatment of various I/R diseases.",
keywords = "Apoptosis, MPO activity, NF-κB expression, Nitrosative stress, Proinflammatory cytokines, SAO shock",
author = "{Di Paola}, Rosanna and Emanuela Esposito and Emanuela Mazzon and Irene Paterniti and Maria Galuppo and Salvatore Cuzzocrea",
year = "2010",
month = "8",
doi = "10.1189/jlb.0110053",
language = "English",
volume = "88",
pages = "291--301",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "2",

}

TY - JOUR

T1 - GW0742, a selective PPAR-β/δ agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury

AU - Di Paola, Rosanna

AU - Esposito, Emanuela

AU - Mazzon, Emanuela

AU - Paterniti, Irene

AU - Galuppo, Maria

AU - Cuzzocrea, Salvatore

PY - 2010/8

Y1 - 2010/8

N2 - PPARs belong to a subfamily of transcription nuclear factors. Three isoforms of PPARs have been identified: α, β/δ, and γ, encoded by different genes and distributed in various tissues. They play important roles in metabolic processes, such as regulation of glucose and lipid redistribution. They also have antiatherogenic, anti-inflammatory, as well as antihypertensive functions. There is good evidence that ligands of PPARs reduce tissue injury associated with I/R. This study investigated the effects of GW0742, a potent and selective PPAR-β/δ agonist, on tissue injury, caused in a mouse model of SAO shock. IRI of the intestine was caused by clamping the superior mesenteric artery and the celiac trunk for 45 min, followed by release of the clamp, allowing reperfusion for 1 or 6 h. Only 10% of the SAO animals survived the entire 6-h reperfusion period. In a separate set of experiments after 60 min of reperfusion, animals were killed for histological examination and biochemical studies. Administration of GW0742 (0.1 mg/ kg, i.p.), 5 min prior to reperfusion, significantly reduced the (1) mortality rate, (2) histological evidence of gut injury, (3) MPO activity, (4) proinflammatory cytokines (TNF-α, IL-1β), (5) adhesion molecules (ICAM-1, P-selectin), (6) nitrotyrosine formation, (7) NF-κB expression, (8) PAR formation, and (9) apoptosis (Bax, Bcl-2, Fas-L, and TUNEL). Based on these findings, we propose that GW0742 would be useful in the treatment of various I/R diseases.

AB - PPARs belong to a subfamily of transcription nuclear factors. Three isoforms of PPARs have been identified: α, β/δ, and γ, encoded by different genes and distributed in various tissues. They play important roles in metabolic processes, such as regulation of glucose and lipid redistribution. They also have antiatherogenic, anti-inflammatory, as well as antihypertensive functions. There is good evidence that ligands of PPARs reduce tissue injury associated with I/R. This study investigated the effects of GW0742, a potent and selective PPAR-β/δ agonist, on tissue injury, caused in a mouse model of SAO shock. IRI of the intestine was caused by clamping the superior mesenteric artery and the celiac trunk for 45 min, followed by release of the clamp, allowing reperfusion for 1 or 6 h. Only 10% of the SAO animals survived the entire 6-h reperfusion period. In a separate set of experiments after 60 min of reperfusion, animals were killed for histological examination and biochemical studies. Administration of GW0742 (0.1 mg/ kg, i.p.), 5 min prior to reperfusion, significantly reduced the (1) mortality rate, (2) histological evidence of gut injury, (3) MPO activity, (4) proinflammatory cytokines (TNF-α, IL-1β), (5) adhesion molecules (ICAM-1, P-selectin), (6) nitrotyrosine formation, (7) NF-κB expression, (8) PAR formation, and (9) apoptosis (Bax, Bcl-2, Fas-L, and TUNEL). Based on these findings, we propose that GW0742 would be useful in the treatment of various I/R diseases.

KW - Apoptosis

KW - MPO activity

KW - NF-κB expression

KW - Nitrosative stress

KW - Proinflammatory cytokines

KW - SAO shock

UR - http://www.scopus.com/inward/record.url?scp=77956399623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956399623&partnerID=8YFLogxK

U2 - 10.1189/jlb.0110053

DO - 10.1189/jlb.0110053

M3 - Article

VL - 88

SP - 291

EP - 301

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 2

ER -